Literature DB >> 11083742

Safety of an intravenous second generation contrast agent in patients with severe left ventricular dysfunction.

P Soman1, A Lahiri, R Senior.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11083742      PMCID： PMC1729500          DOI： 10.1136/heart.84.6.634

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  7 in total

1.  Intravenous injection of Albunex microspheres causes thromboxane mediated pulmonary hypertension in pigs, but not in monkeys or rabbits.

Authors:  J Ostensen; R Hede; Y Myreng; T Ege; E Holtz
Journal:  Acta Physiol Scand       Date:  1992-03

2.  Atrial arrhythmias.

Authors:  F D Murgatroyd; A J Camm
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

Review 3.  Hibernating myocardium.

Authors:  W Wijns; S F Vatner; P G Camici
Journal:  N Engl J Med       Date:  1998-07-16       Impact factor: 91.245

4.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias.

Authors:  H F Clemo; M A Wood; D M Gilligan; K A Ellenbogen
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

5.  Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography.

Authors:  M Ragosta; G Camarano; S Kaul; E R Powers; I J Sarembock; L W Gimple
Journal:  Circulation       Date:  1994-06       Impact factor: 29.690

6.  Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group.

Authors:  P R Kowey; J H Levine; J M Herre; A Pacifico; B D Lindsay; V J Plumb; D L Janosik; H A Kopelman; M M Scheinman
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

7.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.

Authors:  E Galve; T Rius; R Ballester; M A Artaza; J M Arnau; D García-Dorado; J Soler-Soler
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094
  7 in total
  1 in total

Review 1.  Clinical uses of microbubbles in diagnosis and treatment.

Authors:  David Cosgrove; Chris Harvey
Journal:  Med Biol Eng Comput       Date:  2009-02-10       Impact factor: 2.602
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.